However, there was no difference in AKR1A1, DCLRE1C, DHTKD1, PARP1, PTER, and STK39 expression levels between MLL-r ALL and non-MLL-r ALL patients (not shown). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.